Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion.

PubWeight™: 1.70‹?› | Rank: Top 3%

🔗 View Article (PMID 11289128)

Published in Cancer Res on March 15, 2001

Authors

F E Alexander1, S L Patheal, A Biondi, S Brandalise, M E Cabrera, L C Chan, Z Chen, G Cimino, J C Cordoba, L J Gu, H Hussein, E Ishii, A M Kamel, S Labra, I Q Magalhães, S Mizutani, E Petridou, M P de Oliveira, P Yuen, J L Wiemels, M F Greaves

Author Affiliations

1: Department of Public Health Science, University of Edinburgh, United Kingdom.

Articles citing this

Risk factors for acute leukemia in children: a review. Environ Health Perspect (2007) 2.57

Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect (2003) 2.27

Etoposide-initiated MLL rearrangements detected at high frequency in human primitive hematopoietic stem cells with in vitro and in vivo long-term repopulating potential. Eur J Haematol (2008) 2.15

A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia. Int J Epidemiol (2010) 1.95

Childhood leukaemia. BMJ (2002) 1.75

Causes of oncogenic chromosomal translocation. Trends Genet (2005) 1.65

Estrogen treatment induces MLL aberrations in human lymphoblastoid cells. Leuk Res (2009) 1.48

Fluorescence in situ hybridization is necessary to detect an association between chromosome aberrations and polycyclic aromatic hydrocarbon exposure in utero and reveals nonrandom chromosome involvement. Environ Mol Mutagen (2007) 1.42

Perspectives on the causes of childhood leukemia. Chem Biol Interact (2012) 1.41

Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Haematologica (2010) 1.33

Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia. Proc Natl Acad Sci U S A (2002) 1.16

Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia. Proc Natl Acad Sci U S A (2002) 1.16

Fetal mouse Cyp1b1 and transplacental carcinogenesis from maternal exposure to dibenzo(a,l)pyrene. Cancer Prev Res (Phila) (2008) 1.05

A systematic review and meta-analysis of childhood leukemia and parental occupational pesticide exposure. Environ Health Perspect (2009) 1.05

Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics. Cancer Causes Control (2013) 0.97

Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agents. Int J Environ Res Public Health (2012) 0.97

Residential exposures to pesticides and childhood leukaemia. Radiat Prot Dosimetry (2008) 0.95

Tobacco smoke exposure and the risk of childhood acute lymphoblastic and myeloid leukemias by cytogenetic subtype. Cancer Epidemiol Biomarkers Prev (2013) 0.92

Early life exposure to infections and risk of childhood acute lymphoblastic leukemia. Int J Cancer (2010) 0.92

Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism. Am J Hum Genet (2011) 0.91

Early G2/M checkpoint failure as a molecular mechanism underlying etoposide-induced chromosomal aberrations. J Clin Invest (2005) 0.90

In utero pesticide exposure and leukemia in Brazilian children < 2 years of age. Environ Health Perspect (2012) 0.89

Chemoprevention of dibenzo[a,l]pyrene transplacental carcinogenesis in mice born to mothers administered green tea: primary role of caffeine. Carcinogenesis (2008) 0.89

Parental occupational pesticide exposure and the risk of childhood leukemia in the offspring: findings from the childhood leukemia international consortium. Int J Cancer (2014) 0.88

ARID5B polymorphism confers an increased risk to acquire specific MLL rearrangements in early childhood leukemia. BMC Cancer (2014) 0.88

Identifying efficacious approaches to chemoprevention with chlorophyllin, purified chlorophylls and freeze-dried spinach in a mouse model of transplacental carcinogenesis. Carcinogenesis (2008) 0.88

Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia. Blood (2015) 0.88

Do pesticides cause childhood cancer? Int Arch Occup Environ Health (2006) 0.85

Maternal prenatal cigarette, alcohol and illicit drug use and risk of infant leukaemia: a report from the Children's Oncology Group. Paediatr Perinat Epidemiol (2011) 0.85

Rearrangements of the MLL gene are influenced by DNA secondary structure, potentially mediated by topoisomerase II binding. Genes Chromosomes Cancer (2009) 0.85

Reliability of maternal-reports regarding the use of household pesticides: experience from a case-control study of childhood leukemia. Cancer Epidemiol (2012) 0.85

HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk. Blood (2012) 0.83

Epidemiology of childhood acute myeloid leukemia. Pediatr Blood Cancer (2013) 0.83

Molecular pathogenesis of secondary acute promyelocytic leukemia. Mediterr J Hematol Infect Dis (2011) 0.83

ATM modulates the loading of recombination proteins onto a chromosomal translocation breakpoint hotspot. PLoS One (2010) 0.83

Pkb/Akt1 mediates Wnt/GSK3β/β-catenin signaling-induced apoptosis in human cord blood stem cells exposed to organophosphate pesticide monocrotophos. Stem Cells Dev (2012) 0.81

Children's Oncology Group's 2013 blueprint for research: epidemiology. Pediatr Blood Cancer (2012) 0.81

Treatment of infant leukemias: challenge and promise. Hematology Am Soc Hematol Educ Program (2013) 0.80

Maternal exposure to household chemicals and risk of infant leukemia: a report from the Children's Oncology Group. Cancer Causes Control (2011) 0.80

Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls. Fam Cancer (2014) 0.80

Human placental glutathione S-transferase activity and polycyclic aromatic hydrocarbon DNA adducts as biomarkers for environmental oxidative stress in placentas from pregnant women living in radioactivity- and chemically-polluted regions. Toxicol Lett (2010) 0.79

Polymorphisms in CYP1B1, CYP3A5, GSTT1, and SULT1A1 Are Associated with Early Age Acute Leukemia. PLoS One (2015) 0.79

RAS mutations in early age leukaemia modulated by NQO1 rs1800566 (C609T) are associated with second-hand smoking exposures. BMC Cancer (2014) 0.79

Dysregulation of the DNA Damage Response and KMT2A Rearrangement in Fetal Liver Hematopoietic Cells. PLoS One (2015) 0.77

Linking Pesticide Exposure with Pediatric Leukemia: Potential Underlying Mechanisms. Int J Mol Sci (2016) 0.77

MLL leukemia-associated rearrangements in peripheral blood lymphocytes from healthy individuals. Genet Mol Biol (2009) 0.77

Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair. Oncotarget (2016) 0.77

Childhood Leukemia and Primary Prevention. Curr Probl Pediatr Adolesc Health Care (2016) 0.76

Autism, Mitochondria and Polybrominated Diphenyl Ether Exposure. CNS Neurol Disord Drug Targets (2016) 0.76

Maternal vitamin and iron supplementation and risk of infant leukaemia: a report from the Children's Oncology Group. Br J Cancer (2010) 0.76

Knowing the enemy: ant behavior and control in a pediatric hospital of Buenos Aires. Springerplus (2014) 0.75

High birth weight as an important risk factor for infant leukemia. Br J Cancer (2008) 0.75

Maternal Smoking and the Risk of Cancer in Early Life - A Meta-Analysis. PLoS One (2016) 0.75

Maternal Alcohol Consumption during Pregnancy and Early Age Leukemia Risk in Brazil. Biomed Res Int (2015) 0.75

MLL-Rearranged Leukemias-An Update on Science and Clinical Approaches. Front Pediatr (2017) 0.75

Articles by these authors

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (1985) 30.47

RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature (1970) 19.89

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A (2001) 6.70

A one-step purification of membrane proteins using a high efficiency immunomatrix. J Biol Chem (1982) 6.70

Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens. Clin Exp Immunol (1971) 6.43

Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A (2006) 6.33

Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood (1988) 6.09

The cellular basis of immunological responses. A synthesis of some current views. Lancet (1969) 6.05

Sequence of retrovirus provirus resembles that of bacterial transposable elements. Nature (1980) 5.95

The earliest angiosperms: evidence from mitochondrial, plastid and nuclear genomes. Nature (1999) 5.85

Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature (1994) 5.70

The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell (1992) 5.39

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood (1997) 4.78

Noninvasive imaging of in vivo blood flow velocity using optical Doppler tomography. Opt Lett (1997) 4.48

Expression of the CD34 gene in vascular endothelial cells. Blood (1990) 4.41

Phase-resolved optical coherence tomography and optical Doppler tomography for imaging blood flow in human skin with fast scanning speed and high velocity sensitivity. Opt Lett (2000) 4.33

neurogenin1 is essential for the determination of neuronal precursors for proximal cranial sensory ganglia. Neuron (1998) 4.25

Prenatal origin of acute lymphoblastic leukaemia in children. Lancet (1999) 4.21

Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc Natl Acad Sci U S A (1995) 4.16

DNA sequence and comparative analysis of chimpanzee chromosome 22. Nature (2004) 4.12

Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia (1999) 4.09

New insights to the MLL recombinome of acute leukemias. Leukemia (2009) 4.07

Purification of human T and B lymphocytes. J Immunol (1974) 4.00

Ethnic differences in general practitioner consultations. BMJ (1989) 3.98

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet (1998) 3.91

In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood (1996) 3.81

The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development (1999) 3.74

Adult T-cell lymphoma-leukaemia in Blacks from the West Indies. Lancet (1982) 3.67

Light control of Arabidopsis development entails coordinated regulation of genome expression and cellular pathways. Plant Cell (2001) 3.60

Y-Chromosome evidence for a northward migration of modern humans into Eastern Asia during the last Ice Age. Am J Hum Genet (1999) 3.60

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood (1997) 3.56

Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala. Science (1999) 3.40

A DNA-depenent DNA polymerase and a DNA endonuclease in virions of Rous sarcoma virus. Nature (1970) 3.31

Evidence for the direct involvement of the rhinovirus canyon in receptor binding. Proc Natl Acad Sci U S A (1988) 3.29

Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control (2002) 3.27

Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J Biol Chem (2001) 3.27

A family of proteins that inhibit signalling through tyrosine kinase receptors. Nature (1997) 3.26

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia (2008) 3.23

Biological effects of anti-immunoglobulins: evidence for immunoglobulin receptors on 'T' and 'B' lymphocytes. Transplant Rev (1970) 3.23

Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J (1999) 3.22

In vitro synthesis of an infectious RNA from cDNA clones of human rhinovirus type 14. J Virol (1985) 3.19

Molecular cloning and complete sequence determination of RNA genome of human rhinovirus type 14. Proc Natl Acad Sci U S A (1985) 3.17

Blocking of the lymphocyte receptor site for cell mediated hypersensitivity and transplantation reactions by anti-light chain sera. Nature (1969) 3.17

Deprivation and general practitioner workload. BMJ (1992) 3.13

Antisera to acute lymphoblastic leukemia cells. Clin Immunol Immunopathol (1975) 3.12

Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection. Leukemia (2005) 3.09

Genetically engineered Saccharomyces yeast capable of effective cofermentation of glucose and xylose. Appl Environ Microbiol (1998) 3.05

Socioeconomic differentials in the uptake of medical care in Great Britain. J Epidemiol Community Health (1987) 2.99

Effect of trends on detrended fluctuation analysis. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 2.95

Evidence for an important role of WRKY DNA binding proteins in the regulation of NPR1 gene expression. Plant Cell (2001) 2.90

In vivo effect of haemodilution with saline on coagulation: a randomized controlled trial. Br J Anaesth (2002) 2.88

Structure and origin of the acute promyelocytic leukemia myl/RAR alpha cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene (1991) 2.86

IL-1 stimulates IL-6 production in endothelial cells. J Immunol (1989) 2.85

Prevalence and genotypes of alpha- and beta-thalassemia carriers in Hong Kong -- implications for population screening. N Engl J Med (1997) 2.82

Positional cloning of the mouse saccharin preference (Sac) locus. Chem Senses (2001) 2.75

Dentinogenesis imperfecta 1 with or without progressive hearing loss is associated with distinct mutations in DSPP. Nat Genet (2001) 2.75

Monoclonal antibodies OKT 11 and OKT 11A have pan-T reactivity and block sheep erythrocyte "receptors". Eur J Immunol (1982) 2.72

Cell surface markers for human T and B lymphocytes. Eur J Immunol (1974) 2.70

Dosimetric effects of needle divergence in prostate seed implant using 125I and 103Pd radioactive seeds. Med Phys (2000) 2.67

A genetic analysis of neural progenitor differentiation. Neuron (2001) 2.66

Dual bidirectional promoters at the mouse dhfr locus: cloning and characterization of two mRNA classes of the divergently transcribed Rep-1 gene. Mol Cell Biol (1989) 2.66

Expression of an antigen associated with acute lymphoblastic leukemia in human leukemia-lymphoma cell lines. J Natl Cancer Inst (1978) 2.66

Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin Cancer Res (2001) 2.65

Optical Doppler tomographic imaging of fluid flow velocity in highly scattering media. Opt Lett (1997) 2.64

Delayed hypersensitivity and lymphocyte transformation in Crohn's disease and proctocolitis. Gut (1969) 2.61

Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nat Genet (2001) 2.55

Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc Natl Acad Sci U S A (1997) 2.54

Terminal transferase-positive human bone marrow cells exhibit the antigenic phenotype of common acute lymphoblastic leukemia. J Immunol (1979) 2.53

Studies on antigen-binding cells. I. The origin of reactive cells. Cell Immunol (1970) 2.53

Modulation of Ca(2+) entry by polypeptides of the inositol 1,4, 5-trisphosphate receptor (IP3R) that bind transient receptor potential (TRP): evidence for roles of TRP and IP3R in store depletion-activated Ca(2+) entry. Proc Natl Acad Sci U S A (1999) 2.52

Ultrastructural localization of bcl-2 protein. J Histochem Cytochem (1992) 2.48

Lack of serological relationship among DNA polymerases of avian leukosis-sarcoma viruses, reticuloendotheliosis viruses, and chicken cells. J Virol (1973) 2.46

Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci U S A (1997) 2.45

Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality. Oncogene (2001) 2.42

Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J Natl Cancer Inst (1999) 2.41

Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS) Blood (1997) 2.40

Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature (1987) 2.40

Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci U S A (1998) 2.39

Activation of T and B lymphocytes by insoluble phytomitogens. Nat New Biol (1972) 2.39

Lymphocyte activation. II. discriminating stimulation of lymphocyte subpopulations by phytomitogens and heterologous antilymphocyte sera. Clin Exp Immunol (1972) 2.37

Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol (2001) 2.37

Fire and flood management of coastal swamp enabled first rice paddy cultivation in east China. Nature (2007) 2.36

Infectious and noninfectious recombinant clones of the provirus of SNV differ in cellular DNA and are apparently the same in viral DNA. Cell (1980) 2.35

The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat Immunol (2001) 2.32

Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med (2000) 2.31

Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia (2009) 2.30

Incidence of fractures compared to cardiovascular disease and breast cancer: the Women's Health Initiative Observational Study. Osteoporos Int (2008) 2.27

Health risks associated with bathing in sea water. BMJ (1991) 2.24

Acute lymphoblastic leukaemia in children: Classification and prognosis. Lancet (1978) 2.24

A radiation hybrid map of the cat genome: implications for comparative mapping. Genome Res (2000) 2.22

Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells. Genome Res (2000) 2.21

Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor. J Biol Chem (2000) 2.19

In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature (1993) 2.19

Juvenile myelomonocytic leukemia. Blood (1997) 2.19

Anticipation of the difficult airway: preoperative airway assessment, an educational and quality improvement tool. Br J Anaesth (2013) 2.18

Surveillance of the first case of human avian influenza A (H7N9) virus in Beijing, China. Infection (2013) 2.18

Enumeration of absolute numbers of T and B lymphocytes in human blood. Scand J Immunol (1974) 2.16